Stockreport

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial [Yahoo! Finance]

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES, December 03, 2024 BUSINESS WIRE Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing therapies to surmount curre [Read more]